Advancing Healthcare Across Key Therapeutic Areas
Pinninternational is dedicated to addressing significant health challenges through a focused and expanding portfolio of pharmaceutical products.
Our commitment lies in delivering effective and high-quality treatments across several key therapeutic areas where unmet medical needs persist. We combine deep scientific expertise with a patient-centric approach to develop solutions that make a meaningful difference. Explore our current offerings and discover the innovative research driving our future.”
Our Commercially Available Medicines
Pinninternational is proud to offer a range of high-quality, approved medicines that support healthcare professionals and improve the lives of patients in our current markets. Each product reflects our commitment to safety, efficacy, and accessibility.
NeuroClear
NeuroClear™ is indicated for the symptomatic treatment of patients with mild to moderate Alzheimer's disease or other age-related neurocognitive disorders, demonstrating benefits in memory, attention, and daily functioning when initiated in early stages. (TH): NeuroClear
DermaSoothe™
DermaSoothe™ Cream is indicated for the temporary relief of itching, redness, and inflammation associated with various dermatological conditions, including mild to moderate atopic dermatitis (eczema), seborrheic dermatitis, and insect bites. Not for prolonged use without medical advice.
UroFlow™ Max
UroFlow™ Max is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in adult males, helping to improve urine flow and reduce urinary urgency and frequency.
FemBalance™ Daily
FemBalance™ Daily is indicated for women with a uterus for the treatment of moderate to severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis.